Erythromycin eye ointment
Function and Efficacy
Erythromycin is a macrolide antibiotic, which has antibacterial activity against Staphylococcus, various groups of Streptococcus and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. may also be sensitive to this product. This product also has antibacterial activity against various anaerobic bacteria except Bacteroides fragilis and Fusobacterium; it also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can pass through the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis. Erythromycin is only effective against bacteria that actively divide.
Ingredients
Erythromycin
| Name | Description | Content | CAS NO. | Manufacturer |
|---|---|---|---|---|
| ErythromycinIngredients |
Erythromycin is a macrolide antibiotic, which has antibacterial activity against Staphylococcus, various groups of Streptococcus and Gram-positive bacilli. Neisseria, Haemophilus influenzae, Bordetella pertussis, etc. may also be sensitive to this product. This product also has antibacterial activity against various anaerobic bacteria except Bacteroides fragilis and Fusobacterium; it also has inhibitory effects on Legionella, Campylobacter fetus, some spirochetes, Mycoplasma pneumoniae, Rickettsia and Chlamydia. This product is an antibacterial agent, but it also has a bactericidal effect on some bacteria at high concentrations. This product can pass through the bacterial cell membrane and reversibly bind to the 50S subunit of the bacterial ribosome near the donor site (P site), blocking the transfer RNA (t-RNA) binding to the P site, and also blocking the displacement of the polypeptide chain from the acceptor site (A site) to the P site, thereby inhibiting bacterial protein synthesis. Erythromycin is only effective against bacteria that actively divide. More |
114-07-8 | 43 |
Appearance
This product is a white, light yellow or yellow ointment.
Indication
1. Trachoma, conjunctivitis, keratitis. 2. Prevent neonatal gonococcal and Chlamydia trachomatis eye infections.
Usage and Dosage
Apply to eyelids several times a day.
Adverse Reactions
Eye irritation, redness, and other allergic reactions may occur.
Precautions
It is contraindicated in patients who are allergic to erythromycin.
Special Population Medication
Precautions for children: Not yet clear. Precautions for pregnancy and lactation: Not yet clear. Precautions for the elderly: Not yet clear.
Drug Interactions
Not yet clear.
Storage
Keep tightly closed in a cool, dry place.
Packaging Specification
2.5 g: 12.5 mg (0.5%)
Validity Period
60 months.
Manufacturer
Shandong Bausch & Lomb Freda Pharmaceutical Co., Ltd.
-
Founded in:
1992-03-31 -
Address:
No. 789, Xinluo Street, Jinan High-tech Development Zone -
Tax NO.:
913701006140705563 -
Registered Funds:
90 million yuan -
Website:
-
Email: